Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is increasingly recognized as a hallmark of neurodegeneration. Activated central nervous system–resident microglia and infiltrating immune cells contribute to the degeneration of dopaminergic neurons (DNs). However, how the inflammatory process leads to neuron loss and whether blocking this response would be beneficial to disease progression remains largely unknown. CD95 is a mediator of inflammation that has also been proposed as an apoptosis inducer in DNs, but previous studies using ubiquitous deletion of CD95 or CD95L in mouse models of neurodegeneration have generated conflicting results. Here we examine the role of CD95 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP)–induced neurodegeneration using tissue-specific deletion of CD95 or CD95L. We show that DN death is not mediated by CD95-induced apoptosis because deletion of CD95 in DNs does not influence MPTP-induced neurodegeneration. In contrast, deletion of CD95L in peripheral myeloid cells significantly protects against MPTP neurotoxicity and preserves striatal dopamine levels. Systemic pharmacological inhibition of CD95L dampens the peripheral innate response, reduces the accumulation of infiltrating myeloid cells, and efficiently prevents MPTP-induced DN death. Altogether, this study emphasizes the role of the peripheral innate immune response in neurodegeneration and identifies CD95 as potential pharmacological target for neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Pharmacological neutralization of CD95L protects mice against MPTP toxicity and alters peripheral immune response. (A) Scheme of MPTP and APG112 treatment. (B) Quantification of total TH+ DNs in the SNpc at day 6 after last administration of saline or MPTP of control or APG112-treated mice. ANOVA followed by Newman–Keuls post-hoc test: control versus MPTP: *, P < 0.001; MPTP versus MPTP + APG112: †, P < 0.01. (C) Representative images of TH+ neurons in SNpc of control and APG112-treated mice. Bar, 100 µm. (D) Quantification of striatal DA levels using HPLC at day 6 after last administration of saline or MPTP to control or APG112-treated mice. (E) Calculation of the metabolite ratio [(DOPAC + HVA/DA) × 100] after quantification of striatal DA metabolite levels by HPLC. (D and E) Data are presented as mean ± SEM; n = 8. ANOVA on ranks, Student–Newman–Keuls multiple comparison: *, P < 0.05; **, P < 0.01; ***, P < 0.001. (F) HPLC measurement of striatal MPP+ levels in WT and WT + APG112 mice at 90 min after MPTP injection. Data are presented as mean ± SEM; n = 3. Student’s t test: n.s., not significant. (G) Representative dot plots of blood monocytes and gating scheme of flow cytometry. (H) Quantification of blood monocyte subsets by FACS at day 6 after last administration of saline or MPTP of control or APG112-treated mice. ANOVA followed by Newman–Keuls post-hoc test: *, P < 0.05. (B and H) Data are presented as dot plot with median and were pooled from two independent experiments; n = 16–17.](https://figures.cochat.ai/paper-figures/bb2d2197122447e48d9a6f017bfdc066/infiltration-of-circulating-myeloid-cells-through-cd95l-contributes-to-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sialoadhesin (SIGLEC1; also known as CD169) is a marker for mature dendritic cells and macrophages in both mice and humans48 and has been proposed as a marker for invading monocyte-derived macrophages in the CNS as it is not expressed in microglia in health or disease49–52.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 1×
“Recent studies show conclusively that adult microglia derive from yolk sac myeloid progenitors at E8 and are distinct from monocyte-derived macrophages (Ginhoux et al., 2010; Schulz et al., 2012; Kierdorf et al., 2013a).”
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Self-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 1×
“Expression of P2Y12, a metabotropic purinergic receptor, was observed in central microglia but not in peripheral myeloid cells (Haynes et al., 2006).”
BackgroundMicroglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Self-citationHuman CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S.-Y., Senechal, B., Puel, A., Biswas, S. K., Moshous, D., Picard, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.012 · Cited by 1,249
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“Microglial activation and release of proinflammatory factors have been clearly associated with degeneration of SNpc DNs (Liberatore et al., 1999; Wu et al., 2002).”
BackgroundBrochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 5×
“BM chimeric mice were generated according to previously reported studies with modifications (Cui et al., 2002; Mildner et al., 2007).”
BackgroundMethodSelf-citationInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804 · cited 2×
“Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice Liang Gao,1* David Brenner,1* Enric Llorens-Bobadilla,1 Gonzalo Saiz-Castro,1 Tobias Frank,2 Peter Wieghofer,3,4 Oliver Hill,6 Meinolf Thiemann,6 Saoussen Karray,7 Marco Prinz,3,5 Jochen H. Weishaupt,8 and Ana Martin-Villa…”
BackgroundGlial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Self-citationPriller, J., Flügel, A., Wehner, T., Boentert, M., Haas, C. A., Prinz, M., Fernández-Klett, F., Prass, K., Bechmann, I., de Boer, B. A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1356 · Cited by 637
Self-citationModulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
Mildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445
Self-citationThe CD95 Receptor: Apoptosis Revisited
Peter, M. E., Budd, R. C., Desbarats, J., Hedrick, S. M., Hueber, A.-O., Newell, M. K., Owen, L. B., Pope, R. M., Tschopp, J., Wajant, H., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.031 · Cited by 395
Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., & Sonntag, K. C. (2009) · Brain · doi:10.1093/brain/awn323 · Cited by 354
Mildner, A., Schlevogt, B., Kierdorf, K., Böttcher, C., Erny, D., Kummer, M. P., Quinn, M., Brück, W., Bechmann, I., Heneka, M. T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6209-10.2011 · Cited by 351 · cited 1×
“Despite the difference in developmental origin, microglia share similar features with other myeloid cells such as the expression of Fc, complement receptors, CD11b, F4/80, CX3CR1, and other epitopes typically expressed by myeloid monocytes (Prinz and Mildner 2011).”
BackgroundSelf-citationUse of ibuprofen and risk of Parkinson disease
Gao, X., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31820f2d79 · Cited by 321
Fas engagement induces neurite growth through ERK activation and p35 upregulation
Desbarats, J., Birge, R. B., Mimouni-Rongy, M., Weinstein, D. E., Palerme, J.-S., & Newell, M. K. (2003) · Nature Cell Biology · doi:10.1038/ncb916 · Cited by 312
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309
Self-citationTaylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.
Roths, J. B., Murphy, E. D., & Eicher, E. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.1.1 · Cited by 299
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295 · cited 1×
“Interestingly, a recent publication reported that classical monocytes were enriched in the blood of PD patients and demonstrated a pathological hyperactivity, which correlated with disease severity (Grozdanov et al., 2014).”
BackgroundSelf-citationCzłonkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Monocytes: subsets, origins, fates and functions
Yona, S., & Jung, S. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283324f80 · Cited by 260
Programmed Cell Death in Parkinson's Disease
Venderova, K., & Park, D. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009365 · Cited by 247
Microglia in the CNS: Immigrants from another world
Prinz, M., & Mildner, A. (2011) · Glia · doi:10.1002/glia.21104 · Cited by 235
Self-citationRos-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · cited 2×
“Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice Liang Gao,1* David Brenner,1* Enric Llorens-Bobadilla,1 Gonzalo Saiz-Castro,1 Tobias Frank,2 Peter Wieghofer,3,4 Oliver Hill,6 Meinolf Thiemann,6 Saoussen Karray,7 Marco Prinz,3,5 Jochen H. Weishaupt,8 and Ana Martin-Villa…”
BackgroundNeutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury
Demjen, D., Klussmann, S., Kleber, S., Zuliani, C., Stieltjes, B., Metzger, C., Hirt, U. A., Walczak, H., Falk, W., Essig, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1007 · Cited by 217
Enhanced and accelerated lymphoproliferation in Fas-null mice.
Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N., & Nagata, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2131 · Cited by 203
Bone Marrow Cell Recruitment to the Brain in the Absence of Irradiation or Parabiosis Bias
Kierdorf, K., Katzmarski, N., Haas, C. A., & Prinz, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058544 · Cited by 165
Self-citationRole of microglial IKKβ in kainic acid-induced hippocampal neuronal cell death
Cho, I.-H., Hong, J., Suh, E. C., Kim, J. H., Lee, H., Lee, J. E., Lee, S., Kim, C.-H., Kim, D. W., Jo, E.-K., et al. (2008) · Brain · doi:10.1093/brain/awn230 · Cited by 159
Letellier, E., Kumar, S., Sancho-Martinez, I., Krauth, S. J., Funke-Kaiser, A., Laudenklos, S., Konecki, K., Klußmann, S., Corsini, N. S., Kleber, S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.01.011 · Cited by 137
Self-citationCorsini, N. S., Sancho-Martinez, I., Laudenklos, S., Glagow, D., Kumar, S., Letellier, E., Koch, P., Teodorczyk, M., Kleber, S., Klussmann, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.004 · Cited by 129
Self-citationHayley, S., Crocker, S. J., Smith, P. D., Shree, T., Jackson-Lewis, V., Przedborski, S., Mount, M., Slack, R., Anisman, H., & Park, D. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4564-03.2004 · Cited by 125
Association between Parkinson's disease and the HLA‐DRB1 locus
Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 119
Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
Zuliani, C., Kleber, S., Klussmann, S., Wenger, T., Kenzelmann, M., Schreglmann, N., Martinez, A., del Rio, J. A., Soriano, E., Vodrazka, P., et al. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401720 · Cited by 117
The soluble form of Fas molecule is elevated in parkinsonian brain tissues
Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P. F., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13257-2 · Cited by 108
Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study
Diserbo, M., Agin, A., Lamproglou, I., Mauris, J., Staali, F., Multon, E., & Amourette, C. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-070 · Cited by 106
Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice
Cui, Y., Hisha, H., Yang, G.-X., Fan, T.-X., Jin, T., Li, Q., Lian, Z., & Ikehara, S. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703766 · Cited by 95
Kokovay, E., & Cunningham, L. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.023 · Cited by 88
Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease
Funk, N., Wieghofer, P., Grimm, S., Schaefer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 81
Self-citationKarray, S., Kress, C., Cuvellier, S., Hue-Beauvais, C., Damotte, D., Babinet, C., & Lévi-Strauss, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2118 · Cited by 79
Self-citationCD95 in cancer: tool or target?
Martín-Villalba, A., Llorens-Bobadilla, E., & Wollny, D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.002 · Cited by 75
Self-citationRodriguez, M., Alvarez-Erviti, L., Blesa, F. J., Rodríguez-Oroz, M. C., Arina, A., Melero, I., Ramos, L. I., & Obeso, J. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.024 · Cited by 67
Fas and Fas‐L expression in Huntington's disease and Parkinson's disease
Ferrer, I., Blanco, R., Cutillas, B., & Ambrosio, S. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00267.x · Cited by 62
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease
Landau, A. M., Luk, K. C., Jones, M.-L., Siegrist-Johnstone, R., Young, Y. K., Kouassi, E., Rymar, V. V., Dagher, A., Sadikot, A. F., & Desbarats, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050163 · Cited by 50
Frank, T., Klinker, F., Falkenburger, B. H., Laage, R., Lühder, F., Göricke, B., Schneider, A., Neurath, H., Desel, H., Liebetanz, D., et al. (2012) · Brain · doi:10.1093/brain/aws054 · Cited by 33
Self-citationTerrazzino, S., Bauleo, A., Baldan, A., & Leon, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00013-9 · Cited by 33
Cited by
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Valdearcos, M., Douglass, J. D., Robblee, M. M., Dorfman, M. D., Stifler, D. R., Bennett, M. L., Gerritse, I., Fasnacht, R., Barres, B. A., Thaler, J. P., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.015 · Cited by 477
“Consistent with this hypothesis, HFD-fed mice had a significant rise in MBH cells expressing CD169 (Siglec1), which marks monocyte-derived cells, but not resident microglia (Butovsky et al., 2012; Gao et al., 2015) (Figures 3E and 3F).”
InfluentialLee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Rice, R. A., Spangenberg, E. E., Yamate-Morgan, H., Lee, R. J., Arora, R. P. S., Hernandez, M. X., Tenner, A. J., West, B. L., & Green, K. N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0336-15.2015 · Cited by 270
Metadata
- Authors
- Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., Weishaupt, J. H., & Martin-Villalba, A.
- Affiliations
- German Cancer Research Center (DE)
- Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany 1
- Universitätsmedizin Göttingen (DE)
- University of Freiburg (DE)
- Apogenix (Germany) (DE)
- Inserm (FR)
- Universität Ulm (DE)
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-03-16
- Volume
- 212
- Issue
- 4
- Pages
- 469-480
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4387281
- OpenAlex
- W2135833206
- Cited by
- 42
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 2 · 2018: 9 · 2017: 3 · 2016: 8 · 2015: 4
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OPUS (Augsburg University) (submittedVersion, cc-by-nc-sa)
- HAL (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by-nc-sa)
- GRO (submittedVersion, cc-by-nc-sa)
- Funders
- Deutsches Krebsforschungszentrum
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Fas, Fas ligand, neurodegeneration, dopaminergic neurons, MPTP-induced neurotoxicity, neuroinflammation, apoptosis, striatal dopamine, tissue-specific gene deletion
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Immunity, Innate, Inflammation, Apoptosis, Mice, Knockout, fas Receptor, Parkinsonian Disorders, Myeloid Cells, Mice, Fas Ligand Protein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.